HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells

Table 1 Characteristics of the HIV-1-infected men followed longitudinally before and after initiation of antiretroviral treatment that are shown in Figures 3 and 4

PRE/POST Antiretroviral treatment	Number or Median (IQR)
Number of patients	16
Age (years)	36 (24–40)
Antiretroviral treatment regimen
Non-Nucleoside Reverse Transcriptase Inhibitors	8
Protease Inhibitors	7
Integrase Inhibitors	1
Time from diagnosis to antiretroviral treatment (months)	2 (1.5-5)
Time between samples (months)	11 (7–19)
CD4⁺ T-cell count (cells/μl)
PRE antiretroviral treatment	297 (239–316)
POST antiretroviral treatment	505 (401–597)
Plasma Viral Load (Log₁₀ HIV RNA copies/ml)
PRE antiretroviral treatment	5 (4.4-5.5)
POST antiretroviral treatment	1.7 (1.4-1.7)

ISSN: 1742-4690